Lasix issue divides racing industry

9/23/2011 12:52 PM  | drf.com
I'm a fan
My Favorite

The Thoroughbred Owners and Breeders Association is lining up allies and pressing its effort to get state racing commissions to ban the race-day use of the anti-bleeding medication furosemide in 2-year-old races next year, but there are significant hurdles.


TOBA has already begun discussing the proposal with racing commissions in the five states where graded stakes for 2-year-olds are held. Lined up behind TOBA, at least philosophically, are the Jockey Club, the Breeders’ Cup, and the Stronach Group, the private company that owns Santa Anita in California and Gulfstream in Florida, among other tracks.


Horsemen’s groups remain united in opposition to the proposal. The horsemen’s position will complicate efforts to pass rules that would be in effect for 2012 even when factoring in the additional time afforded by the 2-year-old racing calendar, which does not start until April.

Read More

 

What the Nation is saying about Lasix issue divides racing industry...